695 related articles for article (PubMed ID: 23594300)
1. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
4. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
[TBL] [Abstract][Full Text] [Related]
5. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
6. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
7. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
8. [Compared with colloidal silica and porous silica as baicalin solid dispersion carrier].
Yan HM; Ding DM; Wang J; Sun E; Jia XB; Zhang ZH
Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2484-8. PubMed ID: 25276968
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
11. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
12. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Vadia N; Rajput S
Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
[TBL] [Abstract][Full Text] [Related]
13. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
[TBL] [Abstract][Full Text] [Related]
14. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
[TBL] [Abstract][Full Text] [Related]
15. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
16. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
[TBL] [Abstract][Full Text] [Related]
18. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
20. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]